LipoScience, Inc.'s Vantera® Clinical Analyzer to Provide Hospitals and Physicians With Lipoprotein Analysis for Cardiovascular Disease Management
5/23/2013 9:04:59 AM
More...
|
LipoScience, Inc. to Present at UBS Global Healthcare Services Conference
5/14/2013 9:08:41 AM
More...
|
LipoScience, Inc. Reports First Quarter 2013 Financial Results
5/10/2013 9:32:34 AM
More...
|
LipoScience, Inc. to Release First Quarter Fiscal Year 2013 Financial Results
5/3/2013 10:21:07 AM
More...
|
LipoScience, Inc. Begins Clinical Development of NMR-Based Cardiovascular Diagnostic Test for Novel Gut Flora Metabolite
4/26/2013 10:44:47 AM
More...
|
LipoScience, Inc. to Release Fourth Quarter and Fiscal Year 2012 Financial Results
3/12/2013 11:27:10 AM
More...
|
LipoScience, Inc. Release: New Data Further Links Lipoprotein Particles to Cardiovascular Disease Risk
3/12/2013 9:38:02 AM
More...
|
LipoScience, Inc. Lowers IPO Price Range to $9; a 32% Cut
1/25/2013 8:02:46 AM
More...
|
LipoScience, Inc. Collaborates With a Leading Academic Medical Center to Identify Risk Factors Aimed at Improving Management of Acute Coronary Syndrome
1/9/2013 9:47:18 AM
More...
|
LipoScience, Inc. Presents Scientific Data Highlighting New Findings Related to Lipoprotein Particles
11/7/2012 9:25:36 AM
More...
|
|